Go Pro

Braskem (BAK) Competitors

Braskem logo
$2.50 +0.02 (+0.81%)
Closing price 06/26/2026 03:59 PM Eastern
Extended Trading
$2.45 -0.05 (-1.96%)
As of 04:45 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BAK vs. CSW, MEOH, AVNT, CC, and NGVT

Should you buy Braskem stock or one of its competitors? MarketBeat compares Braskem with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Braskem include CSW Industrials (CSW), Methanex (MEOH), Avient (AVNT), Chemours (CC), and Ingevity (NGVT). These companies are all part of the "chemicals" industry.

How does Braskem compare to CSW Industrials?

CSW Industrials (NYSE:CSW) and Braskem (NYSE:BAK) are both chemicals companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, profitability, risk and valuation.

CSW Industrials has higher earnings, but lower revenue than Braskem. Braskem is trading at a lower price-to-earnings ratio than CSW Industrials, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CSW Industrials$1.08B4.26$112.04M$6.6842.30
Braskem$12.66B0.08-$1.77B-$4.22N/A

CSW Industrials has a beta of 0.84, indicating that its stock price is 16% less volatile than the broader market. Comparatively, Braskem has a beta of 1.57, indicating that its stock price is 57% more volatile than the broader market.

CSW Industrials currently has a consensus price target of $328.57, indicating a potential upside of 16.30%. Braskem has a consensus price target of $3.40, indicating a potential upside of 36.00%. Given Braskem's higher probable upside, analysts plainly believe Braskem is more favorable than CSW Industrials.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CSW Industrials
0 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
3 Strong Buy rating(s)
2.78
Braskem
5 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.50

82.8% of CSW Industrials shares are owned by institutional investors. 1.3% of CSW Industrials shares are owned by insiders. Comparatively, 0.0% of Braskem shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

CSW Industrials has a net margin of 10.35% compared to Braskem's net margin of -13.72%. CSW Industrials' return on equity of 15.91% beat Braskem's return on equity.

Company Net Margins Return on Equity Return on Assets
CSW Industrials10.35% 15.91% 9.05%
Braskem -13.72%-23.17%2.72%

In the previous week, CSW Industrials had 3 more articles in the media than Braskem. MarketBeat recorded 8 mentions for CSW Industrials and 5 mentions for Braskem. CSW Industrials' average media sentiment score of 1.37 beat Braskem's score of -0.04 indicating that CSW Industrials is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CSW Industrials
7 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Braskem
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
2 Very Negative mention(s)
Neutral

Summary

CSW Industrials beats Braskem on 13 of the 16 factors compared between the two stocks.

How does Braskem compare to Methanex?

Braskem (NYSE:BAK) and Methanex (NASDAQ:MEOH) are both chemicals companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation.

73.5% of Methanex shares are owned by institutional investors. 0.0% of Braskem shares are owned by company insiders. Comparatively, 1.0% of Methanex shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Braskem has a beta of 1.57, suggesting that its stock price is 57% more volatile than the broader market. Comparatively, Methanex has a beta of 0.56, suggesting that its stock price is 44% less volatile than the broader market.

Methanex has a net margin of -1.25% compared to Braskem's net margin of -13.72%. Methanex's return on equity of 2.96% beat Braskem's return on equity.

Company Net Margins Return on Equity Return on Assets
Braskem-13.72% -23.17% 2.72%
Methanex -1.25%2.96%1.12%

In the previous week, Braskem had 1 more articles in the media than Methanex. MarketBeat recorded 5 mentions for Braskem and 4 mentions for Methanex. Methanex's average media sentiment score of 0.46 beat Braskem's score of -0.04 indicating that Methanex is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Braskem
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
2 Very Negative mention(s)
Neutral
Methanex
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Braskem currently has a consensus target price of $3.40, suggesting a potential upside of 36.00%. Methanex has a consensus target price of $66.78, suggesting a potential upside of 38.89%. Given Methanex's stronger consensus rating and higher probable upside, analysts plainly believe Methanex is more favorable than Braskem.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Braskem
5 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.50
Methanex
1 Sell rating(s)
5 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.45

Methanex has lower revenue, but higher earnings than Braskem. Methanex is trading at a lower price-to-earnings ratio than Braskem, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Braskem$12.66B0.08-$1.77B-$4.22N/A
Methanex$3.59B1.04$79.88M-$0.49N/A

Summary

Methanex beats Braskem on 12 of the 17 factors compared between the two stocks.

How does Braskem compare to Avient?

Braskem (NYSE:BAK) and Avient (NYSE:AVNT) are both chemicals companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk.

In the previous week, Braskem had 4 more articles in the media than Avient. MarketBeat recorded 5 mentions for Braskem and 1 mentions for Avient. Avient's average media sentiment score of 0.85 beat Braskem's score of -0.04 indicating that Avient is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Braskem
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
2 Very Negative mention(s)
Neutral
Avient
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Braskem has a beta of 1.57, meaning that its share price is 57% more volatile than the broader market. Comparatively, Avient has a beta of 1.28, meaning that its share price is 28% more volatile than the broader market.

Avient has lower revenue, but higher earnings than Braskem. Braskem is trading at a lower price-to-earnings ratio than Avient, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Braskem$12.66B0.08-$1.77B-$4.22N/A
Avient$3.26B1.06$81.90M$1.7221.95

Braskem presently has a consensus price target of $3.40, suggesting a potential upside of 36.00%. Avient has a consensus price target of $45.71, suggesting a potential upside of 21.07%. Given Braskem's higher possible upside, analysts plainly believe Braskem is more favorable than Avient.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Braskem
5 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.50
Avient
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.43

Avient has a net margin of 4.81% compared to Braskem's net margin of -13.72%. Avient's return on equity of 11.11% beat Braskem's return on equity.

Company Net Margins Return on Equity Return on Assets
Braskem-13.72% -23.17% 2.72%
Avient 4.81%11.11%4.40%

95.5% of Avient shares are owned by institutional investors. 0.0% of Braskem shares are owned by insiders. Comparatively, 0.9% of Avient shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Avient beats Braskem on 12 of the 16 factors compared between the two stocks.

How does Braskem compare to Chemours?

Chemours (NYSE:CC) and Braskem (NYSE:BAK) are both chemicals companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, media sentiment, analyst recommendations, institutional ownership, dividends, valuation and profitability.

76.3% of Chemours shares are held by institutional investors. 0.9% of Chemours shares are held by company insiders. Comparatively, 0.0% of Braskem shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Chemours currently has a consensus price target of $24.60, suggesting a potential upside of 19.16%. Braskem has a consensus price target of $3.40, suggesting a potential upside of 36.00%. Given Braskem's higher possible upside, analysts plainly believe Braskem is more favorable than Chemours.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Chemours
1 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.42
Braskem
5 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.50

Chemours has higher earnings, but lower revenue than Braskem. Chemours is trading at a lower price-to-earnings ratio than Braskem, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chemours$5.81B0.53-$386M-$2.64N/A
Braskem$12.66B0.08-$1.77B-$4.22N/A

Chemours has a net margin of -6.82% compared to Braskem's net margin of -13.72%. Chemours' return on equity of 52.49% beat Braskem's return on equity.

Company Net Margins Return on Equity Return on Assets
Chemours-6.82% 52.49% 1.78%
Braskem -13.72%-23.17%2.72%

In the previous week, Chemours had 3 more articles in the media than Braskem. MarketBeat recorded 8 mentions for Chemours and 5 mentions for Braskem. Chemours' average media sentiment score of 0.28 beat Braskem's score of -0.04 indicating that Chemours is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Chemours
2 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Neutral
Braskem
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
2 Very Negative mention(s)
Neutral

Chemours has a beta of 1.4, indicating that its stock price is 40% more volatile than the broader market. Comparatively, Braskem has a beta of 1.57, indicating that its stock price is 57% more volatile than the broader market.

Summary

Chemours beats Braskem on 11 of the 16 factors compared between the two stocks.

How does Braskem compare to Ingevity?

Ingevity (NYSE:NGVT) and Braskem (NYSE:BAK) are both chemicals companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, profitability, valuation, risk and institutional ownership.

Ingevity has a net margin of -10.55% compared to Braskem's net margin of -13.72%. Ingevity's return on equity of 207.82% beat Braskem's return on equity.

Company Net Margins Return on Equity Return on Assets
Ingevity-10.55% 207.82% 9.70%
Braskem -13.72%-23.17%2.72%

In the previous week, Braskem had 2 more articles in the media than Ingevity. MarketBeat recorded 5 mentions for Braskem and 3 mentions for Ingevity. Ingevity's average media sentiment score of 1.20 beat Braskem's score of -0.04 indicating that Ingevity is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ingevity
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Braskem
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
2 Very Negative mention(s)
Neutral

Ingevity has higher earnings, but lower revenue than Braskem. Ingevity is trading at a lower price-to-earnings ratio than Braskem, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ingevity$1.18B2.26-$167.10M-$3.55N/A
Braskem$12.66B0.08-$1.77B-$4.22N/A

Ingevity currently has a consensus target price of $80.00, indicating a potential upside of 4.61%. Braskem has a consensus target price of $3.40, indicating a potential upside of 36.00%. Given Braskem's higher probable upside, analysts clearly believe Braskem is more favorable than Ingevity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ingevity
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20
Braskem
5 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.50

Ingevity has a beta of 1.18, meaning that its stock price is 18% more volatile than the broader market. Comparatively, Braskem has a beta of 1.57, meaning that its stock price is 57% more volatile than the broader market.

91.6% of Ingevity shares are owned by institutional investors. 0.9% of Ingevity shares are owned by company insiders. Comparatively, 0.0% of Braskem shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Ingevity beats Braskem on 11 of the 16 factors compared between the two stocks.

Get Braskem News Delivered to You Automatically

Sign up to receive the latest news and ratings for BAK and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BAK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BAK vs. The Competition

MetricBraskemOIL IndustryEnergy SectorNYSE Exchange
Market Cap$996.50M$89.15B$9.54B$23.30B
Dividend YieldN/A3.65%10.58%4.08%
P/E Ratio-0.5914.4918.9731.64
Price / Sales0.081.69760.1920.94
Price / Cash1.446.5736.8218.60
Price / Book-0.341.374.064.75
Net Income-$1.77B$4.71B$4.25B$1.07B
7 Day Performance-14.82%-6.95%-2.57%1.36%
1 Month Performance-40.25%-12.25%-6.38%0.70%
1 Year Performance-21.75%25.78%30.28%25.30%

Braskem Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BAK
Braskem
2.694 of 5 stars
$2.50
+0.8%
$3.40
+36.0%
-21.8%$996.50M$12.66BN/A8,233
CSW
CSW Industrials
4.3636 of 5 stars
$270.74
-1.3%
$328.57
+21.4%
-7.4%$4.43B$1.08B40.592,700
MEOH
Methanex
3.6681 of 5 stars
$51.76
-1.9%
$66.78
+29.0%
+40.8%$4.06B$3.59BN/A1,649
AVNT
Avient
4.4188 of 5 stars
$36.74
-1.4%
$45.71
+24.4%
+14.8%$3.37B$3.26B21.399,000
CC
Chemours
3.7106 of 5 stars
$20.99
-2.2%
$24.60
+17.2%
+76.5%$3.12B$5.82BN/A5,700

Related Companies and Tools


This page (NYSE:BAK) was last updated on 6/29/2026 by MarketBeat.com Staff.
From Our Partners